On-Treatment Response-Guided Therapy With Telaprevir Q8h Or Q12h Combined With Peginterferon Alfa-2a Or Peginterferon Alfa-2b And Ribavirin In Treatment-Naive Genotype 1 Hepatitis C (Study C208)

Conclusion:For treatment of patients with chronic hepatitis C genotype 1 infection with pegylated interferon 2b and ribavirin complete individualization and optimization of treatment duration is possible according to baseline viral load and first time HCV RNA negativity at week 4, 6, 8, 12 and 24.Complete individualized treatment durations may also be useful for STAT-C triple treatment schedules.